CKD: Progression and Diabetes (2001)
CKD Progression and persons with Diabetes; Glycemic Control in Diabetes for persons with CKD (2001)
What is the evidence on the progression of chronic kidney disease in patients with either diabetes types 1 or 2? (2001 CD)
Glycemic control and effective treatment of hypertension and proteinuria has been shown to be effective in delaying the onset and progression of chronic kidney disease in patients with both diabetes type 1 and 2. The Diabetes Complications and Control Trial in patients with type 1 diabetes mellitus and the United Kingdom Prospective Diabetes Study in patients with Type 2 diabetes mellitus demonstrated that intensive treatment resulting in near normal A1C reduced the incidence of microabuminuria and diabetic nephropathy.
- Grade I means there is Good/Strong evidence supporting the statement;
- Grade II is Fair;
- Grade III is Limited/Weak;
- Grade IV is Expert Opinion Only;
- Grade V is Not Assignable.
- High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
- Moderate (B) means we are moderately confident in the effect estimate;
- Low (C) means our confidence in the effect estimate is limited;
- Very Low (D) means we have very little confidence in the effect estimate.
- Ungraded means a grade is not assignable.
Evidence Summary: Glycemic Control of Diabetes in Chronic Kidney Disease (2001)
- Quality Rating Summary
For a summary of the Quality Rating results, click here.
- American Diabetes Association. Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care. 2002; 25(Suppl 1):S33-S49.
- Bakris GL, Siomos M, Richardson D, Janssen I, Bolton WK, Hebert L, Agarwal R, Catanzaro D. ACE inhibition or angiotensin receptor blockade: Impact on potassium in renal failure. Kidney Int 2000; 58:2084-2092.
- Beto J. Which diet for which renal failure: Making sense of the options. J Am Diet Assoc 1995; 95: 898-903.
- Cianciaruso B, Bellizzi V, Minutolo R, Tavera A, Capuano A, Conte G, De Nicola L. Salt intake and renal outcome in patients with progressive renal disease. Miner Electrolyte Metab 1998;24:296-301.
- The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
- Delahanty LM. Implications of the diabetes control and complications trial for renal outcomes and medical nutrition therapy. J Renal Nutr. 1998; 8: 59-63.
- Ellis D, Lloyd C, Becker DJ, Forrest KY, Orchard TJ. The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria. Am J Kidney Disease 1996;27:809-818.
- Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: A meta-analysis. Kidney Int 2001; 59:260-269.
- Irvin B. The progression and treatment of diabetic nephropathy. Top Clin Nutr 1996; 12:31-40.
- Keane WF, Eknoyan G. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation. Am J Kidney Diseases 1999; 33:1004-1010.
- Mailloux LU, Levey AS. Hypertension in patients with chronic renal disease. Am J Kidney Diseases 1998; 32(Suppl 3): S120-S141.
- Muirhead N. The rationale for early management of chronic renal insufficiency. Nephrol Dial Transplant 2001;16 (suppl 7): 51-56.
- Weir MR. Impact of salt intake on blood pressure and proteinuria in diabetes: importance of the renin-angiotensin system. Miner Electrolyte Metab 1998; 24:438-445.
- Yamamoto ME, Olson MB, Fine J, Powers S, Stollar C. The effect of sodium restriction and weight reduction on blood pressure of patients with hypertension and chronic renal disease. J Renal Nutr. 1997; 7: 25-32.